Financhill is a comprehensive financial analysis platform that provides stock analysis, market data, investment tools, and educational resources to help investors make informed decisions.

How do I get started with Financhill?

You can start by creating a free account, exploring our stock analysis tools, setting up a watchlist, or trying our 7-day trial for full access to all premium features.

What features does Financhill offer?

Financhill offers stock analysis, technical charts, fundamental data, earnings information, dividend tracking, portfolio management, market screening tools, and educational resources.

How accurate are stock forecasts?

Stock forecasts are based on technical and fundamental analysis but should not be considered as guaranteed predictions. Past performance does not guarantee future results.

How do I analyze VRTX stock?

Use our comprehensive analysis tools including technical charts, fundamental metrics, earnings data, and Stock Score to evaluate VRTX investment potential.

What is VRTX stock price today?

Get real-time VRTX stock price, historical data, and price charts on Financhill. Track VRTX performance with our advanced analysis tools.

Is VRTX a good investment?

Evaluate VRTX investment potential using our Stock Score, fundamental analysis, technical indicators, and earnings data. Consider your risk tolerance and investment goals.

How to buy VRTX stock?

To buy VRTX stock, open a brokerage account, research the company using our analysis tools, and place your order through your broker. Always do your own research before investing.

What is the market cap of VRTX?

View detailed market capitalization data and company valuation metrics for VRTX on our comprehensive analysis page.

What is the P/E ratio of VRTX?

Use our fundamental analysis tools to view VRTX P/E ratio and compare valuation metrics with industry peers.

What are VRTX earnings?

View VRTX earnings data, quarterly results, revenue growth, and profit margins on our comprehensive earnings analysis page. Track earnings trends and analyst estimates.

Back

Vertex Pharmaceuticals, Inc. Stock Predictions

This AI Layer Just Raised Its Share Price

DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi

Buy

VRTX
Vertex Pharmaceuticals, Inc.

Last Price:

$457.41

Seasonality Move:

13.72%

7 Day Trial

ALL ACCESS PASS

$ 7

$0.85 Entry Open - Fortune 1000 AI Tech in Demand

Vertex Pharmaceuticals, Inc. Stock Forecast

Over the next 52 weeks, Vertex Pharmaceuticals, Inc. has on average historically risen by 27.8% based on the past 34 years of stock performance.
Vertex Pharmaceuticals, Inc. has risen higher in 20 of those 34 years over the subsequent 52-week period, corresponding to a historical accuracy of 58.82%
Is Vertex Pharmaceuticals, Inc. Stock Undervalued?

The current Vertex Pharmaceuticals, Inc. [VRTX] share price is $463.13. The Score for VRTX is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
VRTX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.

Will Vertex Pharmaceuticals, Inc. Stock Go Up Next Year?

Over the next 52 weeks, Vertex Pharmaceuticals, Inc. has on average historically risen by 27.8% based on the past 34 years of stock performance.

Vertex Pharmaceuticals, Inc. Stock Rating

Buy

Vertex Pharmaceuticals, Inc. (VRTX) is a Buy

Is Vertex Pharmaceuticals, Inc. overpriced?

Vertex Pharmaceuticals, Inc. has risen higher in 20 of those 34 years over the subsequent 52-week period, corresponding to a historical accuracy of 58.82%

Vertex Pharmaceuticals, Inc. Stock Price History

Is VRTX stock going to rise?

Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and VRTX is experiencing buying pressure, which is a positive indicator for future bullish movement.

Stock Information

Stock Info

Exchange:

S&P500

Country:

United States

Industry:

Biotechnology

Sector:

Health Care

Type:

stock

Website:

vrtx.com

52-Week Data

52-Week High:

519.68

52-Week Low:

362.50

Prediction Charts

Market Cap:

117.5B

Price in USD:

463.13

Volume:

2.5M

Beta:

0.93

Technical Analysis

SMA50:

418.13

SMA100:

415.28

SMA200:

443.02

52-Wk Change:

1.35%

Stock Predictions

Is Vertex Pharmaceuticals, Inc. stock public?

Yes, Vertex Pharmaceuticals, Inc. is a publicly traded company.
What is the Vertex Pharmaceuticals, Inc. stock quote today?

The Vertex Pharmaceuticals, Inc. stock price is 463.13 USD today.
How to buy Vertex Pharmaceuticals, Inc. stock online?

You can buy Vertex Pharmaceuticals, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date	Opening	Closing	Minimum	Maximum
Nov-13	434.02	434.52	441.23	430.66
Nov-14	440.02	437.15	442.22	433.67
Nov-17	436.99	434.02	439.99	432.24
Nov-18	434.00	435.52	437.79	430.15
Nov-19	434.36	421.03	434.93	418.53
Nov-20	420.84	422.32	431.13	420.00
Nov-21	423.13	426.76	435.85	421.87
Nov-24	426.23	424.00	432.55	423.87
Nov-25	425.92	429.82	431.50	424.12
Nov-26	432.43	432.17	433.32	428.07
Nov-28	434.67	433.61	434.67	429.07
Dec-1	431.92	425.60	434.00	423.46
Dec-2	427.34	433.15	435.20	424.06
Dec-3	440.31	463.13	463.85	439.35

Vertex Pharmaceuticals, Inc. Earnings

Vertex Pharmaceuticals, Inc. Earnings Report: Per Share Vertex Pharmaceuticals, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.

Vertex Pharmaceuticals, Inc. Forecast Revenue Growth

Vertex Pharmaceuticals, Inc. Stock Analysis: Historical quarterly revenues per share for Vertex Pharmaceuticals, Inc. and historical quarterly revenue growth:

Analysts estimate an earnings increase this quarter of $0.46 per share, a decrease next quarter of $0.00 per share, an increase this year of $17.96 per share, and an increase next year of $1.75 per share.

* Vertex Pharmaceuticals, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.